logo
Sign in

CytoVale, Inc

SAN FRANCISCO, CA · Medtech · Private

IntelliSep, an FDA-cleared sepsis detection test using the Cytovale System medical device that analyzes cellular deformability

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · cytovale.com

Sector
Medtech
Headquarters
SAN FRANCISCO, CA
Latest Form D
$8M, Jan 2021
Total capital
$26M
Federal grants
$3.3M
4 awards · 2015–2017
Rank in peer group#260 of 477
Private capital raised
$22.7M
3 Form D · last Jan 2021
70 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
10
10 pending · first 2019
Rank in peer group#25 of 477

Capital timeline

2015201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $26M$350K$750K$1.5M$734K1st Form D$7.2M2nd Form D$7.4M3rd Form D$8M
2015201720192021FEDERAL ↑EQUITY ↓Cumulative $26M$350K$750K$1.5M$734K1st Form D$7.2M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$8M
  • Private capital raisedForm D · SEC · 2nd filing$7.4M
  • Private capital raisedForm D · SEC · 1st filing$7.2M
  • Federal grantHealth and Human S · Phase II · Enabling Point of Care Screening for Sepsis Using Rapid Single Cell Analysis$734K
  • Federal grantHealth and Human S · Phase II · Enabling Point of Care Screening for Sepsis Using Rapid Single Cell Analysis$1.5M
  • Federal grantHealth and Human S · Phase II · Enabling Point of Care Screening for Sepsis Using Rapid Single Cell Analysis$750K
  • Federal grantHealth and Human S · Phase I · Biomechanical enrichment of malignant cells enabling companion diagnostics$350K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

31months

from CytoVale, Inc’s first federal award to its first private round.

First federal award · Jun 2015
Health and Human S · $350K
First Form D · Dec 2017
$7.2M · 1st Form D
Awards before first raise
4 awards

An association in public records, not a cause or a prediction.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#25 · top 5%
  • Linked publications#20 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Henry TseResearcherExecutive OfficerLinked by 1 patent · $350K in grants as PI
  • Ajay ShahResearcherExecutive Officer, Director, PromoterLinked by $3M in grants as PI
  • Dino DiCarloDirector, PromoterNamed in SEC Form D filings
  • Jack FuchsDirector, PromoterNamed in SEC Form D filings
  • Jordanna Polis SchutzDirectorNamed in SEC Form D filings
  • Lindy FishburneDirectorNamed in SEC Form D filings
Show all 7 people
  • William BlackledgeExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 10 granted of 20
Show all 20 patent records

Recent research by its founders

  • Temporal trends of a cellular host response test for sepsis and a comparison with selected biomarkers of inflammation and infection20251 cites
  • Validation of a Novel, Rapid Sepsis Diagnostic for Emergency Department Use202411 cites
  • Cellular host response sepsis test for risk stratification of patients in the emergency department: A pooled analysis20249 cites

Related companies, and why

  • STRATEOS SUB, INC.Similar federal contract value in Medtech · null in contracts
  • EPIWATCH, INC.Similar federal contract value in Medtech · null in contracts
  • D4Z4 MEDICINE, INC.Similar federal contract value in Medtech · null in contracts
  • Thermalin Inc.Similar federal contract value in Medtech · null in contracts
  • ENTVANTAGE DIAGNOSTICS, INCSimilar federal contract value in Medtech · null in contracts
  • PERCEPTIVE NAVIGATION LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .